Mintr Compass
$230.75
RMD · ResMed|
36 Weak · Mid Horizon
36Weak
Price Action47
Business Quality63
Market Confidence12
AI READ as of 2026-08-20
Trading Avoid
  • Current price movement lacks clear direction
  • Performance lags behind the broader market
  • Recent news coverage remains inconsistent
Investing Neutral
  • The company maintains a solid financial foundation
  • Future expansion appears to be slowing down
  • Healthcare companies face a complex and competitive landscape
Price & Momentum · Trading
Technical
60
Rel. Strength
48
Momentum
60
Proximity
22
Sentiment
9
Business & Value · Investing
Quality
74
Balance Sheet
81
Growth
44
Valuation
51
Analyst
16
Open RMD in Compass →
Ratings current as of 2026-08-19. Price live as of 2026-08-20 14:30 UTC. Algorithmic percentile rankings from historical and delayed data — not investment advice or a recommendation to buy or sell any security. Markets involve risk including loss of principal. Methodology · Terms · Privacy